Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Braz. J. Anesth. (Impr.) ; 73(2): 220-222, March-Apr. 2023. graf
Article in English | LILACS | ID: biblio-1439601

ABSTRACT

Abstract Burning mouth syndrome is a poorly understood entity for which current treatment modalities fail to provide effective relieve. Branches of the maxillary and mandibular nerves are responsible for the innervation of the affected area. These are also the nerves involved in trigeminal neuralgia, an entity where sphenopalatine block has proved to be effective. We present a case of a patient with burning mouth syndrome in whom a bilateral sphenopalatine ganglion block was successfully performed for pain treatment. It is an easy and safe technique that can be a valuable treatment option for these patients, although more studies are needed.


Subject(s)
Humans , Trigeminal Neuralgia/etiology , Trigeminal Neuralgia/therapy , Burning Mouth Syndrome/complications , Burning Mouth Syndrome/therapy , Sphenopalatine Ganglion Block/methods , Treatment Outcome , Pain Management
2.
Natal; s.n; 30 maio 2022. 77 p. tab, ilus, graf.
Thesis in Portuguese | LILACS, BBO | ID: biblio-1532943

ABSTRACT

Introdução: O manejo de pacientes com ardor bucal é um desafio no cotidiano clínico da odontologia. Objetivo: Comparar o efeito da Terapia a Laser de Baixa Intensidade (LLLT) e da Estimulação Elétrica Nervosa Transcutânea (TENS) no tratamento do ardor bucal. Metodologia: Ensaio clínico randomizado constituído por 25 pacientes com ardor bucal que foram tratados por TENS (n=12) e por LLLT (n=13). Os protocolos de tratamento foram aplicados semanalmente por 8 semanas. O teste análise de variância (ANOVA) dois fatores foi usado para verificar se existia diferença significativa entre os tempos T0 (antes de iniciar o tratamento), T1 (após a 4ª sessão de tratamento), T2 (após a 8ª sessão de tratamento) e T3 (30 dias após o término do tratamento) em relação aos sintomas, analisados por meio da Escala Visual Analógica (EVA), fluxo salivar não estimulado, xerostomia e disgeusia com as intervenções de TENS e LLLT. Resultados: A maioria dos pacientes foi do sexo feminino no período pós-menopausa com média de idade no grupo TENS de 59,25 anos e no grupo LLLT de 62,08. Hipertensão e dislipidemia foram as alterações sistêmicas mais frequentes. Ansiedade e depressão foram os únicos transtornos psiquiátricos relados. A maioria dos pacientes fazia uso de medicamentos como anti-hipertensivos e antidepressivos. Não foram observadas variações expressivas no que se refere a xerostomia e a disgeusia nos dois grupos analisados. A TENS e a LLLT foram eficazes na redução dos sintomas relatados pelos pacientes (p˂0,001), entretanto, observou-se entre os tempos T2 e T3 que o grupo LLLT apresentou uma melhor resposta quando comparado ao TENS (p=0,003). Os pacientes do grupo TENS apresentaram aumento do fluxo salivar entre os tempos T1 e T2, enquanto o grupo LLLT apresentou uma diminuição (p=0,052). Conclusão: A TENS e a LLLT foram eficazes na redução dos sintomas do ardor bucal durante o tratamento e 30 dias após o término do tratamento, sendo que o grupo LLLT apresentou uma melhor resposta na sessão de acompanhamento pós-tratamento quando comparado ao grupo TENS (AU).


Introduction: The management of patients with burning mouth is a challenge in the clinical routine of dentistry. Objective: To compare the effect of Low Intensity Laser Therapy (LLLT) and Transcutaneous Electrical Nerve Stimulation (TENS) in the treatment of burning mouth. Methodology: Randomized clinical trial consisting of 25 patients with burning mouth who were treated with TENS (n=12) and LLLT (n=13). Treatment protocols were applied weekly for 8 weeks. The two-way analysis of variance (ANOVA) test was used to verify whether there was a significant difference between the times T0 (before starting treatment), T1 (after the 4th treatment session), T2 (after the 8th treatment session) and T3 (30 days after the end of treatment) in relation to symptoms, analyzed using the Visual Analogue Scale (VAS), unstimulated salivary flow, xerostomia and dysgeusia with TENS and LLLT interventions. Results: Most patients were female in the postmenopausal period, with a mean age of 59.25 years in the TENS group and 62.08 in the LLLT group. Hypertension and dyslipidemia were the most frequent systemic alterations. Anxiety and depression were the only psychiatric disorders reported. Most patients used drugs such as antihypertensives and antidepressants. Significant variations were not observed with regard to xerostomia and dysgeusia in the two groups analyzed. TENS and LLLT were effective in reducing the symptoms reported by patients (p˂0.001), however, it was observed between times T2 and T3 that the LLLT group showed a better response when compared to TENS (p=0.003). Patients in the TENS group showed an increase in salivary flow between times T1 and T2, while the LLLT group showed a decrease (p=0.052). Conclusion: TENS and LLLT were effective in reducing the symptoms of burning mouth during treatment and 30 days after the end of treatment, and the LLLT group showed a better response in the posttreatment follow-up session when compared to the TENS group (AU).


Subject(s)
Humans , Male , Female , Xerostomia/diagnosis , Burning Mouth Syndrome/therapy , Dysgeusia/therapy , Analysis of Variance , Statistics, Nonparametric , Low-Level Light Therapy/methods , Electric Stimulation/methods
3.
Rev. Odontol. Araçatuba (Impr.) ; 43(1): 12-17, jan.-abr. 2022. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-1361564

ABSTRACT

O presente estudo teve como objetivo principal descrever por meio de um relato de caso clínico o diagnóstico e a conduta clínica de uma paciente portadora da Síndrome da Ardência Bucal (SAB). A SAB é definida como uma dor crônica e de difícil diagnóstico e difícil tratamento. O local mais acometido pela SAB é a língua, lábios e mucosa jugal, mas pode estar presente em qualquer parte da mucosa oral, causando desconforto e interferindo na qualidade de vida do paciente. Paciente do sexo feminino, leucoderma, 39 anos, sem histórico de doenças sistêmicas, saúde geral em bom estado, procurou atendimento no Centro Universitário da Serra Gaúcha ­ FSG por apresentar sensação de ardência recorrente na língua e na mucosa, que aumentava em momentos de estresse ou durante a ingestão de alimentos cítricos, picantes ou quentes. A paciente realizou exames complementares (hemograma completo, glicemia de jejum, exame de vitamina B12) e primeiramente, iniciou-se o tratamento com antifúngico tópico para remoção de uma camada esbranquiçada presente no dorso da língua. Após a remissão desta, foi utilizado AD-Muc tópico 2 vezes ao dia, durante 2 semanas e relatou ter reduzido seus sintomas em torno de 70%. A paciente ainda apresentava xerostomia e, então foi prescrita saliva artificial. A paciente teve a regressão total de seus sintomas. Pode-se concluir que diversos fatores etiológicos estão relacionados com a SAB, porém sua causa específica permanece desconhecida. O tratamento é paliativo, entretanto, o Ad-muc tópico se mostrou eficaz na redução da sintomatologia da SAB juntamente com o uso da saliva artificial(AU)


The present study aimed to describe, through a clinical case report, the diagnosis and clinical conduct of a patient with Burning Mouth Syndrome (BMS). BMSis defined as chronic pain that is difficult to diagnose and difficult to treat. The site most affected by BMS is the tongue, lips, and cheek mucosa, but it can be present in any part of the oral mucosa, causing discomfort and interfering with the patient's quality of life. Female patient, leucoderma, 39 years old, with no history of systemic diseases, general health in good condition, sought care at the Centro Universitário da Serra Gaúcha - FSG for presenting a recurrent burning sensation in the tongue and mucosa, which increased in times of stress or while eating citrus, spicy or hot foods. The patient underwent complementary tests (complete blood count, fasting blood glucose, vitamin B12 test) and first, treatment with topical antifungal was started to remove a whitish layer present on the back of the tongue. After remission, topical AD-Muc was used twice a day for 2 weeks and reported to have reduced his symptoms by around 70%. The patient still had xerostomia and then artificial saliva was prescribed. The patient had a total regression of her symptoms. It can be concluded that several etiological factors are related to SAB, but its specific cause remains unknown. Treatment is palliative, however, topical Ad-muc is effective in reducing the symptomsof BMS also with the use of artificial saliva(AU)


Subject(s)
Humans , Female , Adult , Burning Mouth Syndrome , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Quality of Life , Saliva, Artificial , Xerostomia , Mouth Mucosa , Antifungal Agents
4.
Rev. otorrinolaringol. cir. cabeza cuello ; 82(1): 86-94, mar. 2022. tab, ilus
Article in Spanish | LILACS | ID: biblio-1389836

ABSTRACT

Resumen El síndrome de la boca ardiente (SBA) es una condición de dolor crónico en la cavidad oral, que se presenta mayoritariamente en mujeres de edad media. Diversas causas locales y sistémicas pueden producirlo en forma secundaria, o bien, puede representar un cuadro primario, sin etiología específica identificable. Su etiopatogenia y evolución clínica es poco comprendida. Las opciones terapéuticas son variadas y en general es necesario un tratamiento multidisciplinario. A continuación, se presenta una revisión de la literatura respecto a esta patología para difusión en nuestro medio.


Abstract Burning mouth syndrome (BMS) is a chronic pain condition of the oral cavity, which occurs more frequently in middle-aged women. It can be secondary to different local and systemic causes, or represent a primary condition, with no specific identifiable etiology. Its etiopathogenesis and clinical evolution are poorly understood. Therapeutic options are multiple and a multidisciplinary treatment is necessary. We present a review of the literature regarding BMS, to provide information relevant to our area of expertise.


Subject(s)
Humans , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/epidemiology , Prevalence
5.
Rev. chil. dermatol ; 34(4): 119-125, 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-1103098

ABSTRACT

El Síndrome de Boca Urente (SBU) clásicamente se define como un dolor oral quemante sin hallazgos en el examen físico o de laboratorio. Muchas veces puede ser asociado a procedimientos dentales o alteraciones psiquiátricas pero en En la gran mayoría de los casos, no existe un fenómeno relacionado. Sin embargo, no existe consenso en su evaluación clínica, lo que se refleja en lo heterogéneo de los estudios de prevalencia, patogenia y tratamiento. Es por esto que muchas veces, representa un desafío el diagnóstico y tratamiento, especialmente cuando especialmente cuando existe un serio deterioro de la calidad de vida, sin una causa identificable. Este artículo tiene como objetivo contribuir en la identificación de causas y en la definición de pautas para el diagnostico y manejo clínico del SBU, proponiendo un esquema de estudio y manejo en base a la revisión de la literatura y la experiencia clínica.


Classically, we can define Burning-Mouth Syndrome (BMS) as burnish oral pain with no physical or laboratory findings; often can be associated with dental procedures or psychiatric disorders but in general, there is no related phenomenon. Even today there is confusion and ignorance of this syndrome, being reflected in the heterogeneity of the studies of prevalence, pathogenesis and treatment. This is why, in clinical practice, study and treatment are challenging, especially when we are faced with a patient who feels seriously impaired in his quality of life and does not find the cause. This article attempts to contribute to the understanding of the BMS, proposing a study and management scheme based on literature review and clinical experience.


Subject(s)
Humans , Child , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Burning Mouth Syndrome/etiology
6.
Dolor ; 25(66): 30-37, dic. 2016. tab
Article in Spanish | LILACS | ID: biblio-1096098

ABSTRACT

INTRODUCCIÓN: el síndrome de boca urente (SBU), también conocido como estomatodinia o glosodinia, es una situación de dolor crónico que varía en su intensidad de moderado a severo y que se manifiesta como una disestesia ardiente relacionada a la lengua, pero también afecta frecuentemente la cara interna de los labios y la porción anterior del paladar duro. corresponde a una sensación de ardor continua, con una mucosa oral normal y de la cual no se puede encontrar ninguna causa dental o médica evidente. el SBU se divide en dos tipos: uno primario o idiopático, el cual no se puede asociar a ninguna otra patología, siendo un diagnóstico de exclusión; y uno secundario, el cual puede relacionarse a factores locales o generales, que puedan estar generándolo y que el tratamiento de esta causa conlleva a la resolución del problema. en esta revisión nos enfocaremos al tratamiento del SBU primario, del cual su fisiopatología aún no está clara, y la cual podría estar relacionada a factores periféricos como centrales, teniendo también un rol los problemas psicológicos. al no tener clara en su totalidad la fisiopatología de esta enfermedad, se hace muy difícil el poder tratarla. el objetivo de esta revisión es poder entregar herramientas actuales para su correcto diagnóstico y cuáles son los enfoques terapéuticos actuales que se están utilizando hoy para poder tratar esta enfermedad.


INTRODUCTION: burning mouth syndrome (BMS), also known as stomatodynia or glossodynia, is a chronic pain condition that ranges from moderate to severe, manifesting as a burning dysesthesia usually related to the tongue, but also frequently affects the inner face of the lips and the anterior portion of the hard palate. it corresponds to a continuous burning sensation, derived from a normal oral mucosa and from which no dental or medical cause can be found. the SBU is divided into two types: a primary or idiopathic one that cannot be associated with any other pathology, being a diagnosis of exclusion and a secondary one, which can be related to local or general factors that may be generating it and that the treatment of this cause leads to the resolution of the problem. in this review we will focus on the treatment of the primary SBU, of which its pathophysiology is still unclear, could be related to peripheral or central factors, with psychological problems also related. not being fully aware of the pathophysiology of this disease, it is very difficult to treat it. the objective of this review is to be able to deliver current tools that are being done to treat this disease


Subject(s)
Humans , Burning Mouth Syndrome/therapy , Psychotherapy , Antipsychotic Agents/therapeutic use , Capsaicin/therapeutic use , Laser Therapy , Antidepressive Agents/therapeutic use
8.
Int. j. odontostomatol. (Print) ; 5(1): 23-27, abr. 2011.
Article in English | LILACS | ID: lil-594273

ABSTRACT

El síndrome de boca urente (SBU) es una condición enigmática porque la intensidad de los síntomas rara vez se corresponde con los signos clínicos de la enfermedad. Los síntomas incluyen ardor bucal, boca seca, dolor, cambios en los hábitos alimenticios, graves síntomas de la menopausia, y problemas no específicos de salud, entre otros. SBU es más frecuente en las mujeres posmenopáusicas con relación mujer/hombre de 7:1. La etiología del SBU es multifactorial, como los cambios hormonales (menopausia), las carencias nutricionales y alteraciones del gusto por nombrar algunos. SBU es un reto con respecto al diagnóstico y al manejo. El presente artículo analiza algunos de los acuerdos recientes de la etiopatogenia de SBU, así como el papel de la gestión farmacoterapeutica en este trastorno.


Burning mouth syndrome (BMS) is an enigmatic condition because the intensity of symptoms rarely corresponds to the clinical signs of the disease. Symptoms include oral burning, dry mouth, pain, changes in eating habits, severe menopausal symptoms, and non specific health problems etc. BMS is most prevalent in postmenopausal women with female: male ratio of 7:1. The etiology of BMS is multifactorial such as hormonal changes (menopause), nutritional deficiencies and taste disturbances to name a few. BMS is a challenge to diagnose and manage. The present article discusses some of the recent understanding of etiopathogenesis of BMS as well as the role of pharmacotherapeutic management in this disorder.


Subject(s)
Humans , Burning Mouth Syndrome/epidemiology , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/therapy , Glossalgia
9.
Rev. cuba. estomatol ; 47(4): 417-427, oct.-dic. 2010.
Article in Portuguese | LILACS, CUMED | ID: lil-584519

ABSTRACT

El síndrome de boca ardiente (SBA) es una enfermedad crónica que se caracteriza por una sensación de quemazón de la mucosa bucal, que impresiona clínicamente normal. Es una entidad nosológica frecuente, sin embargo, los mecanismos implicados en su desarrollo en la actualidad son poco conocidos. El objetivo de este trabajo fue llevar a cabo una revisión de la literatura sobre dicho síndrome y se hizo énfasis en sus principales factores etiológicos y en el tratamiento de esta enfermedad. El SBA es una afección multifactorial compleja, debido a la diversidad de sus síntomas, dificultad en el tratamiento y las características psicológicas particulares de los pacientes. El diagnóstico correcto es el elemento principal para establecer el tratamiento. Es necesario realizar nuevas investigaciones para aclarar con precisión las causas del SAB, especialmente en la forma primaria(AU)


Burning mouth syndrome (BMS) is a chronic condition characterized by burning sensation on a clinic normal oral mucosa. BMS is not a rare condition, however, mechanisms involved in their development remains poorly understood. The aim of this paper was to carry out a review of literature about this syndrome, highlighting the main etiological factors as an approach to the management of this condition(AU)


Subject(s)
Humans , Burning Mouth Syndrome/diagnosis , Burning Mouth Syndrome/therapy , Burning Mouth Syndrome/epidemiology , Burning Mouth Syndrome/etiology , Review Literature as Topic , Mouth Mucosa/injuries
10.
JKCD-Journal of Khyber College of Dentistry. 2010; 1 (1): 43-47
in English | IMEMR | ID: emr-146330

ABSTRACT

To evaluate and analyse the occurrence, clinical characteristics and treatment outcomes in patients with burning mouth syndrome. Data of sixty patients with burning mouth syndrome reported to the private clinic of the author from January 2003 to March 2008 were reviewed. Clinical examination and treatment follow up was carried out. Data regarding the age, gender, main site of involvement, associated symptoms and treatment outcome were evaluated and analysed. Females outnumbered the males. The most common age group involved was 41 -50years. Main sites of involvement were anterior 213[rd] of tongue [58.6%], followed by labial mucosa [13.3%]. The common complaint associated with burning mouth was dry mouth [90%] followed by taste loss [63.3%]. Significant improvement [91.3%] was noticed in patients managed with the combination of systemic antidepressants, clonazepam and strong reassurance. Burning mouth syndrome was more common in aged females. Common site of involvement was anterior 213[rd] of tongue. Improvements in symptoms were more significant when antidepresssants were combined with clona


pam and strong reassurance


Subject(s)
Humans , Male , Female , Burning Mouth Syndrome/therapy , Treatment Outcome , Antidepressive Agents , Clonazepam , Xerostomia
11.
Braz. j. oral sci ; 8(2): 62-66, Apr.-June 2009. ilus, tab
Article in English | LILACS, BBO | ID: lil-556465

ABSTRACT

Although several studies discuss the contributing factors associated with the burning mouth syndrome (BMS), there is still controversy with regard to its etiology. Therefore, in the majority of cases, the establishment of an adequate diagnosis and consequently the best treatment modality is complicated. In order to assist the clinician in the establishment of the correct diagnosis and management of BMS, this article reviews the literature, providing a discussion on the various etiologic factors involved in BMS, as well as the best treatment modalities for this condition that have showed to be the most effective ones in randomized clinical trials. In addition, the authors discuss some clinical characteristics in the differential diagnosis of BMS and other oral diseases. It is important for the clinician to understand that BMS should be diagnosed only after all other possible causes for the symptoms have been ruled out.


Subject(s)
Humans , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/therapy , Hypersensitivity , Signs and Symptoms , Burning Mouth Syndrome/diagnosis , Mouth Mucosa/pathology , Xerostomia/pathology
12.
Dental Journal-Shahid Beheshti University of Medical Sciences. 2008; 25 (4): 348-356
in Persian | IMEMR | ID: emr-86108

ABSTRACT

Since there are not specific pathogens for most of the intraoral lesions and there is not unique protocol for their therapies and also some of these drugs are not accessible in Iran, we decided to introduce the drugs most available and appropriate in our country. This study has been done by review discussion procedures. The articles were extracted from native, foreign and international journals, medline, books and theses. Whole part of therapies were considered in these articles. The following lesions were discussed in this study: 1- Primary and secondary herpetic gingivostomatitis, 2- Recurrent Aphthus stomatitis, 3- Lichen planus, 4-Candidiasis, 5- Burning sensation in oral cavity, 6- Xerostomia and 7- taste disorder. As we know there are several kinds of medications for each lesion, although most of them have side effects, and some of them can not be found in our country, we have tried to do our best to suggest appropriate drugs for each intraoral disorders


Subject(s)
Disease Management , Stomatitis, Herpetic/therapy , Stomatitis, Aphthous/therapy , Lichen Planus/therapy , Candidiasis/therapy , Burning Mouth Syndrome/therapy , Xerostomia/therapy , Taste Disorders/therapy
13.
Odontol. clín.-cient ; 6(3): 259-262, jul.-set. 2007.
Article in Portuguese | LILACS, BBO | ID: lil-500984

ABSTRACT

A Síndrome de Ardência Bucal (SAB), de etiologia multifatorial, é uma condição na qual os pacientes apresentam-se com generalizada sensação de ardor ou dor na boca, mas não existem anormalidades prontamente reconhecidas na mucosa bucal. É uma dosordem intra-bucal comum que afeta mais as mulheres. A ardência pode ocorrer em muitos sítios dentro ou a redor da cavidade bucal. São reconhecidos três tipos na SAB. O objetivo deste trabalho é realizar uma revisão da literatura acerca da SAB e relatar dois casos clínicos.


Subject(s)
Mouth/pathology , Mouth Abnormalities , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/therapy
14.
SDJ-Saudi Dental Journal [The]. 2007; 19 (3): 128-138
in English | IMEMR | ID: emr-85227

ABSTRACT

Burning mouth syndrome [BMS] is a disorder that is characterized by a burning sensation of the oral cavity in the absence of visible local or systemic abnormalities. Affected patients often present with multiple oral complaints, including burning, dryness and taste alterations. The exact cause of burning mouth syndrome often is difficulttopinpoint. Conditions that have been reported in association with burning mouth syndrome include chronic anxiety or depression, various nutritional deficiencies, type 2 diabetes and change sinsalivary function. Studies have pointed todys function of the cranial nerves associated with taste sensation as a possible cause of burning mouth syndrome. Since burning mouth symptoms may arise as the result of a number of etiologic factors, diagnosis and management of the patient with BMS should involve consideration of all possible causative factors. Hormone replacement therapy, benzodiazepines/ anti-convulsants, anti-depressants, analgesics, capsaicin, alpha-lipoic acid and cognitive behavioral therapy etc. have all been used in the management of BMS. The present review outlines various aspects of BMS, updates current knowledge on the disease, and provides guidelines for successful patient management


Subject(s)
Humans , Burning Mouth Syndrome/etiology , Burning Mouth Syndrome/therapy , Prevalence , Disease Management
SELECTION OF CITATIONS
SEARCH DETAIL